Patents Assigned to CELLSNAP, LLC
  • Neurotoxins and uses thereof
    Patent number: 10751394
    Abstract: The present disclosure relates to neurotoxins and uses thereof. In particular, provided herein are botulinum neurotoxins with altered properties and uses thereof (e.g., research, screening, and therapeutic uses).
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: August 25, 2020
    Assignee: CELLSNAP LLC
    Inventors: Eric A. Johnson, Sabine Pellett, William H. Tepp, Christina Pier, Marite Bradshaw
  • Hybrid neurotoxins and uses thereof
    Patent number: 10688162
    Abstract: The present disclosure relates to chimeric neurotoxins and uses thereof. In particular, provided herein are chimeric botulinum neurotoxins with altered properties and uses thereof (e.g., research, screening, and therapeutic uses).
    Type: Grant
    Filed: January 10, 2018
    Date of Patent: June 23, 2020
    Assignee: CELLSNAP LLC
    Inventors: Eric A. Johnson, Sabine Pellett, William H. Tepp, Marite Bradshaw, Christina L. Pier, Joseph T. Barbieri
  • Compositions and methods for toxigenicity testing
    Patent number: 9217172
    Abstract: The present invention relates to compositions and methods for testing agents (e.g., Clostridium botulinum neurotoxin (BoNT) detection and analysis). In particular, the present invention relates to the use of Human induced pluripotent stem (hiPS) derived cells for agent detection and analysis.
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: December 22, 2015
    Assignee: CELLSNAP, LLC
    Inventors: Eric Arthur Johnson, Sabine Pellett, William Howard Tepp, Regina Clare Meyer Whitemarsh